Atlas Trials

Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of CDX-6114 in Patients With Phenylketonuria (PKU)

Clinical trial NCT04085666 · COMPLETED

Trial details

NCT number
NCT04085666
Sponsor
Société des Produits Nestlé (SPN)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Phenylketonuria
Start date
2019-06-01
Primary completion
2020-06-30
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.